The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Nuvation Bio Inc (NYSE: NUVB) closed the day trading at $2.32 up 2.20% from the previous closing price of $2.27. In other words, the price has increased by $2.20 from its previous closing price. On the day, 1.54 million shares were traded.
Ratios:
For a better understanding of NUVB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.57 and its Current Ratio is at 9.57. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Wang Junyuan Jerry sold 56,361 shares for $2.89 per share. The transaction valued at 162,883 led to the insider holds 3,866,228 shares of the business.
Mashal Robert bought 100,000 shares of NUVB for $220,000 on Oct 08 ’24. The Director now owns 100,000 shares after completing the transaction at $2.20 per share. On Jun 25 ’24, another insider, Cui Xiangmin, who serves as the Director of the company, bought 277,895 shares for $2.97 each. As a result, the insider paid 825,348 and bolstered with 2,453,131 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 362.57 while its Price-to-Book (P/B) ratio in mrq is 1.55.
Stock Price History:
Over the past 52 weeks, NUVB has reached a high of $4.16, while it has fallen to a 52-week low of $1.67. The 50-Day Moving Average of the stock is -10.83%, while the 200-Day Moving Average is calculated to be -17.83%.
Shares Statistics:
A total of 335.25M shares are outstanding, with a floating share count of 224.84M. Insiders hold about 33.39% of the company’s shares, while institutions hold 45.96% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$1.98 and -$1.98 for the fiscal current year, implying an average EPS of -$1.98. EPS for the following year is -$0.51, with 1.0 analysts recommending between -$0.51 and -$0.51.
